The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10701 malaria professionals are enjoying the free benefits of MalariaWorld today


Evaluation of two novel tablet formulations of artemether-lumefantrine (Coartem(R)) for bioequivalence in a randomized, open-label, two-period study

September 9, 2013 - 15:26 -- Open Access
Lefèvre G, Bhad P, Jain J, Kalluri S, Cheng Y, Dave H, Stein DS
Malaria Journal 2013, 12:312 (8 September 2013)

These novel formulations are easy to administer and may improve adherence in the treatment of uncomplicated malaria caused by Plasmodium falciparum.

Medical Condition: 
Subscribe to RSS - coartem